Arcellx's innovative cell therapy platform shows promising potential in treating multiple myeloma, a significant unmet ...
During a live event, John L. Wagner, MD, moderated a discussion on when to refer patients for CAR T-cell therapy and what ...
Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...